Novasign accelerates bioprocess development with AI-powered, hybrid-model digital twins. Their software and services combine first-principles models with machine learning to design, simulate, and optimize upstream and downstream operations for early and late-stage development as well as for manufacturing. They serve biopharmaceutical, food technology, and enzyme manufacturing sectors, aiming to cut experiments, timelines, and costs.